Taysha Gene Therapies Inc (NASDAQ: TSHA): Do Not Miss The Gain Train
Taysha Gene Therapies Inc (TSHA) concluded trading on Thursday at a closing price of $2.56, with 6.64 million shares of worth about $16.99 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 57.06% during that period and on May 15, 2025 the price saw […]
Taysha Gene Therapies Inc (TSHA) Testing Investors’ Patience Right Now
Currently, there are 204.94M common shares owned by the public and among those 165.06M shares have been available to trade. The company’s stock has a 5-day price change of 9.89% and 27.39% over the past three months. TSHA shares are trading 15.61% year to date (YTD), with the 12-month market performance down to -22.48% lower. […]
Analysts Update Their Price Forecasts For Taysha Gene Therapies Inc (TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on Thursday at a closing price of $2.41, with 6.68 million shares of worth about $16.09 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 22.34% during that period and on May 01, 2025 the price saw […]
Growing Through Challenges? – Taysha Gene Therapies Inc (TSHA)
Currently, there are 204.94M common shares owned by the public and among those 165.06M shares have been available to trade. The company’s stock has a 5-day price change of 39.06% and 16.34% over the past three months. TSHA shares are trading 2.89% year to date (YTD), with the 12-month market performance down to -26.14% lower. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Taysha Gene Therapies Inc (NASDAQ: TSHA)
Currently, there are 204.94M common shares owned by the public and among those 165.01M shares have been available to trade. The company’s stock has a 5-day price change of -16.27% and -25.27% over the past three months. TSHA shares are trading -19.65% year to date (YTD), with the 12-month market performance down to -56.15% lower. […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) – Not A Clear Buying Opportunity?
Taysha Gene Therapies Inc (TSHA) concluded trading on Wednesday at a closing price of $2.52, with 6.5 million shares of worth about $16.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.25% during that period and on Wednesday the price saw a gain […]
Is Taysha Gene Therapies Inc (NASDAQ: TSHA) Back In The Buying Zone?
Fidelity Management & Research Co recently announced the acquisition of new stake in Taysha Gene Therapies Inc (NASDAQ:TSHA). The institutional investor has increased its shareholding in the Healthcare company by 2,035.03% to 24.53 million shares with purchase of 23.38 million shares. This fresh investment now brings its stake to 13.12% valued currently at $43.17 million. […]
Some Investing Thoughts On Taysha Gene Therapies Inc (NASDAQ: TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on December 20, 2023 at a closing price of $1.42, with 5.1 million shares of worth about $7.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 98.46% during that period and On Wednesday the price saw […]
